MARIETTA, Ga., April 23, 2018 /PRNewswire/ -- MiMedx Group, Inc.
(NASDAQ: MDXG), a leading developer and marketer of regenerative
and therapeutic biologics, announced that the Company will host its
live broadcast of the Company's first quarter conference call on
April 26, 2018 at 10:30 a.m. eastern time.
A listen-only simulcast of the MiMedx conference call will be
available online at the Company's website at www.mimedx.com.
A 30-day online replay will be available approximately one hour
following the conclusion of the live broadcast. The replay
can also be found on the Company's website at www.mimedx.com.
About MiMedx
MiMedx® is a leading biopharmaceutical
company developing and marketing regenerative and therapeutic
biologics utilizing human placental tissue allografts with
patent-protected processes for multiple sectors of healthcare.
"Innovations in Regenerative Medicine" is the framework
behind the Company's mission to give physicians products and
tissues to help the body heal itself. The Company processes
the human placental tissue utilizing its proprietary PURION®
Process methodology, among other processes, to produce safe and
effective allografts by employing aseptic processing techniques in
addition to terminal sterilization. MiMedx has supplied over 1
million allografts to date for application in the Wound Care, Burn,
Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental
sectors of healthcare. For additional information, please visit
www.mimedx.com.
View original
content:http://www.prnewswire.com/news-releases/mimedx-will-host-its-first-quarter-shareholder-conference-call-on-thursday-april-26-2018-300634580.html
SOURCE MiMedx Group, Inc.